Exelixis (EXEL) Net Margin (2010 - 2026)

Exelixis (EXEL) recorded quarterly Net Margin of 34.46% in Q2 2026, down 15.64% quarter-over-quarter from 40.85% in Q1 2026, and up 572.0% on a YoY basis from 5.13% in Q2 2025.

Exelixis (EXEL) Net Margin (2010 - 2026) Analysis & Trends

Exelixis' Net Margin history runs 17 years deep, the most recent figure standing at 34.46% for Q2 2026.

  • In Q2 2026, Net Margin rose 572.0% year-over-year to 34.46%; the TTM figure through Apr 2026 stood at 35.08% (up 709.0% YoY), while the FY2026 annual figure was 33.73%, up 969.0% from the prior year.
  • Net Margin was 34.46% for Q2 2026 at Exelixis, down from 40.85% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 40.85% in Q1 2026 to a low of 7.12% in Q4 2022.
  • Historically, Net Margin has averaged 20.69% across 5 years, with a median of 19.26% in 2022.
  • Biggest YoY gain for Net Margin was 2495 bps in 2023; the steepest drop was 1756 bps in 2023.
  • A 5-year view of Net Margin shows it stood at 7.12% in 2022, then surged by 350 bps to 17.83% in 2023, then advanced by 23 bps to 21.87% in 2024, then surged by 48 bps to 32.38% in 2025, then advanced by 6 bps to 34.46% in 2026.
  • The last three Net Margin figures came in at 34.46% (Q2 2026), 40.85% (Q1 2026), and 32.38% (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.82%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 34.53%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn 34.46%

Historic Data

Download Data
DateValue
Apr 3, 2026 34.46%
Jan 2, 2026 40.85%
Oct 3, 2025 32.38%
Jul 4, 2025 32.53%
Apr 4, 2025 28.74%
Jan 3, 2025 24.68%
Sep 27, 2024 21.87%
Jun 28, 2024 35.49%
Mar 29, 2024 8.78%
Dec 29, 2023 17.83%
Sep 29, 2023 0.22%
Jun 30, 2023 17.28%
Mar 31, 2023 9.79%
Dec 30, 2022 -7.12%
Sep 30, 2022 17.78%
Jul 1, 2022 16.85%
Apr 1, 2022 19.26%
Oct 1, 2021 11.63%
Jul 2, 2021 24.95%
Apr 2, 2021 0.59%